Intravenous Iron: biomarkers and treatment strategies in anaemic Colorectal cancer patients. - Intravenous Iron: measuring response in anaemic surgical patients

ottingham University Hospital0 个研究点目标入组 20 人开始时间: 2009年5月8日最近更新: 2019年11月25日

适应症

试验速览

暂无简介。

•Age >18yrs
•Diagnosis of Colorectal Cancer and a defined surgical operation date
•Biochemically detectable anaemia.
•Women of child bearing potential (who have a negative pregnancy
•test) must agree to use methods of medically acceptable forms of contraception during the study; (e.g. intra-uterine device (IUD) or a double-barrier method of oral contraception with condom)
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•Patients with a recognised allergy to intravenous iron, or related products.
•A concurrent medical condition(s) that,in the view of the investigator, would prevent compliance or participation or jeopardize the health of the patients.
•Any of the following groups:
•Children; those unable to consent for themselves; pregnant females; prisoners

发起方

ottingham University Hospital